Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism.

Miguel Jiménez-AlcázarAndreas LimacherRachita PandaMarie MéanJosephine BitterlingSven PeineThomas RennéJürg H BeerDrahomir AujeskyBernhard LämmleTobias A Fuchs

Published in: PloS one (2018)

Our study suggests that ceDNA levels in VTE patients reflect the degree of inflammation and may serve as a biomarker to stratify VTE patients at risk for mortality.

Keyphrases

venous thromboembolism
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
oxidative stress
cardiovascular events
risk factors
cardiovascular disease
direct oral anticoagulants
circulating tumor